Response of remission lymphocytes to autochthonous leukaemic myeloblasts
- PMID: 1064430
- PMCID: PMC2024968
- DOI: 10.1038/bjc.1976.81
Response of remission lymphocytes to autochthonous leukaemic myeloblasts
Abstract
Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts.
Similar articles
-
Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.Immunology. 1978 Aug;35(2):299-305. Immunology. 1978. PMID: 155646 Free PMC article.
-
In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.Br J Cancer. 1981 Jan;43(1):13-8. doi: 10.1038/bjc.1981.3. Br J Cancer. 1981. PMID: 6450603 Free PMC article.
-
Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.Br J Cancer. 1977 Mar;35(3):273-9. doi: 10.1038/bjc.1977.39. Br J Cancer. 1977. PMID: 139910 Free PMC article.
-
Effect of thrombopoietin on acute myelogenous leukemia blasts.Leuk Lymphoma. 2000 Mar;37(1-2):27-37. doi: 10.3109/10428190009057626. Leuk Lymphoma. 2000. PMID: 10721767 Review.
-
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].Folia Med Cracov. 2001;42(3):5-80. Folia Med Cracov. 2001. PMID: 12353422 Review. Polish.
Cited by
-
Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.Br J Cancer. 1978 Oct;38(4):481-95. doi: 10.1038/bjc.1978.235. Br J Cancer. 1978. PMID: 281967 Free PMC article.
-
Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.Br J Cancer. 1984 Apr;49(4):485-94. doi: 10.1038/bjc.1984.76. Br J Cancer. 1984. PMID: 6201182 Free PMC article.
-
Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.Clin Exp Immunol. 1977 Aug;29(2):229-39. Clin Exp Immunol. 1977. PMID: 143355 Free PMC article.
-
Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.Clin Exp Immunol. 1979 Jan;35(1):53-61. Clin Exp Immunol. 1979. PMID: 154982 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources